Using tDCS in Speech- Based Stroke Rehabilitation

Clinical Trial

Project funded by the National Institute of Health (R01 DC018589)

In Progress/Currently Recruiting Participants

Study Information

Who can participate:

Individuals with aphasia/apraxia following stroke
English is primary language
Difficulty producing speech

Qualifying participants who have had a stroke and have apraxia of speech will receive up to 24 speech therapy sessions over a 4 to 6 month period, at no charge.

What do we do?

Transcranial direct current stimulation (tDCS), a form of non- invasive brain stimulation, will be used during a portion of speech therapy.
tDCS is considered a non- significant risk device by the FDA, and is safe to use.
Low doses of electrical current will be administered through the scalp over areas that may assist with speech recovery.

For more information, please contact: buchwald-lab@nyu.edu or call 646 612 0284 for a free consultation.